Metabolic Pathway Research · GLP-1 receptor agonist
DulaglutideLong-acting GLP-1 receptor agonist fusion peptide.
An older, established GLP-1 drug useful for completeness in the incretin category.
Also known as Trulicity. CAS No. 1198417-37-6.
Scientific name
Long-acting GLP-1 receptor agonist fusion peptide.
CAS No.
1198417-37-6
Category
Metabolic Pathway Research
US status
Research only
Evidence last verified May 9, 2026
0 results
No vendor products match the selected size.
Scientific Details
Quick Facts
Trulicity
63 kDa
Mechanism of Action
GLP-1 receptor agonism
Glucose-dependent insulin secretion
Glucagon suppression
Key Pathways
Incretin signaling
Glycemic control
Scientific Research
| Year | Title / Journal | Type | Cites |
|---|---|---|---|
| 2019 | Gerstein 2019 — REWIND Dulaglutide Cardiovascular Outcomes The Lancet | RCT | 3568 |
| 2014 | Dungan 2014 — AWARD-6 Dulaglutide vs Liraglutide The Lancet | RCT | 675 |
Showing 2 of 2 papers
Reference
Regulatory Status
USResearch only
EUNot approved
UKResearch only
AUResearch only
Regulatory status may change. Always verify current regulations in your jurisdiction before purchase.